S epsis and septic shock are significant problems in children and adults. Although mortality from sepsis is decreasing, its prevalence is increasing (1) (2) (3) (4) . Despite years of investigation, no specific therapeutic agent for treating sepsis exists (1, 5) .
Studying peripheral blood leukocyte genome-wide expression profiles of children with septic shock, Wong et al (6) identified a subset of children with higher severity of illness, greater organ dysfunction, and increased mortality. The genomic response of these children was characterized by profound suppression of multiple immunologic signaling pathways, including B and T cell receptor pathways, glucocorticoid receptor signaling, and natural killer cell signaling. The peroxisome proliferator-activated receptor (PPAR)-α pathway was also one of the most significantly down-regulated (6) .
PPAR, PPARα, PPARβ/δ, and PPARγ are ligand-activated nuclear receptor transcription factors. They sit at the interface between inflammatory and metabolic pathways and regulate aspects of each (7) . Endogenous PPAR ligands include specific fatty acids and their derivatives. Many exogenous PPAR agonists are used in clinical practice. The fibrate class of drugs activates PPARα, whereas the glitazones function as PPARγ agonists. PPARα is widely expressed in the body (especially in heart, kidney, and liver). It exerts a generally anti-inflammatory influence over the immune response and also regulates fatty acid oxidation (FAO) and lipid transport (7) .
In a previous study, we showed that children with sepsis and septic shock had lower levels of PPARα expression in circulating leukocytes than children without sepsis and that PPARα expression inversely correlated with sepsis severity (8) . We also demonstrated that Ppara -/mice had impaired survival following cecal ligation and puncture (CLP)-induced experimental sepsis. Unexpectedly, we found that Ppara -/mice had lower levels of inflammatory cytokines, reduced leukocyte activation, and increased tissue bacterial load. We concluded that absence of PPARα, presumably in leukocytes, promoted development of a functionally immunosuppressed state (8) .
In the current study, we initially intended to further characterize the role of PPARα in establishing this immunosuppression. Contrary to our initial hypothesis, we found that nonhematopoietic, rather than hematopoietic, expression of PPARα was the critical determinant of survival in experimental murine polymicrobial sepsis. Furthermore, cardiac expression of PPARα was necessary to protect against sepsis-induced cardiac injury.
MATERIALS AND METHODS

Mouse CLP
The University of Washington Office of Animal Welfare approved all animal use and procedures. Wild-type (WT) C57Bl/6J mice and Ppara -/mice on a C57Bl/6 background (B6.129S4-Ppara tm1Gonz /J) from Jackson Laboratory (Sacramento, CA) were bred in our vivarium as homozygous congenic strains. Twelve-to 16-week-old, age-matched males were used for all experiments. Polymicrobial sepsis was induced via CLP as described (8, 9) . Briefly, the cecum was exteriorized through a midline laparotomy and ligated with 3.0-silk suture immediately distal to the ileocecal junction. A single puncture was made with a 25-gauge needle along the antimesenteric aspect of the cecum and light pressure applied to express a small amount (5-10 μL) of fecal material. The cecum was replaced in the abdomen, and the abdominal wall was closed. All animals were resuscitated with 20 mL/kg of normal saline solution (approximately 0.5 mL per mouse) delivered subcutaneously. Mice received subcutaneous imipenem (25 mg/kg in 10 mL/kg normal saline) 2 hours after CLP and then every 12 hours until euthanasia or until 3 days had elapsed. Buprenorphine (0.05 mg/kg) was also administered every 12 hours for 3 days.
Separate groups (5-10/genotype/time point) of age-matched, nontransplanted mice underwent CLP and were euthanized at time 0 (unoperated baseline), 24, 48, and 72 hours after CLP. Blood was collected via cardiac puncture, and plasma was separated by centrifugation. Whole tissue was collected for histologic and gene expression analyses. Plasma and tissue samples were stored at -80°C until batch analysis could be performed.
Survival Studies
After CLP, mice were observed every 12 hours for the first 3 days and then every 24 hours until 7 days following CLP. A clinical scoring tool was used at each observation to monitor severity of illness. Predefined surrogate endpoints for death were established, and mice were euthanized when they met those criteria ( Table 1) . Survivors were euthanized at 7 days.
Bone Marrow Chimeras
Six-to 8-week-old WT and Ppara -/mice were irradiated with 1,000 rad. The next day, bone marrow was isolated from the tibias and femurs of age-and gender-matched donor mice, and 4 × 10 6 cells were injected into the retro-orbital venous plexus of irradiated recipient mice (Supplemental Fig. 1 . 2 , Supplemental Digital Content 2, http://links.lww.com/CCM/B607): WT control (WT recipient transplanted with WT marrow), WT chimera (WT recipient transplanted with Ppara -/marrow), Ppara -/chimera (Ppara -/recipient transplanted with WT marrow), and Ppara -/control (Ppara -/recipient transplanted with Ppara -/marrow).
Six weeks post-transplant, DNA was purified from whole blood (DNeasy Blood and Tissue Kit; Qiagen, Valencia, CA) and polymerase chain reaction (PCR) performed to confirm the genotype of the engrafted marrow (common forward primer: CACACCAAGCAGCAGACACT, PPARα-mutant reverse primer: GCTATCAGGACATAGCGTTGG, WT reverse primer: CCCATTTCGGTAGCAGGTAGTCTT). All mice demonstrated appropriate engraftment with transplanted marrow without evidence of native bone marrow (Supplemental Fig. 3 , Supplemental Digital Content 3, http://links.lww.com/ CCM/B608). Mice that were significantly underweight and appeared malnourished were excluded from the survival study. Remaining mice subsequently underwent CLP, and survival was evaluated over 7 days.
Biomarker Assays
Cardiac troponin-I levels were measured by enzyme-linked immunosorbent assay (Life Diagnostics, West Chester, PA). Blood urea nitrogen (BUN) (Pointe Scientific, Canton, MI), creatinine (Diazyme Laboratories, Poway, CA), and alanine aminotransferase (ALT) (Sigma Aldrich, St. Louis, MO) levels were quantified by using enzyme-based colorimetric assays. Blood glucose levels were measured with the Contour Next glucometer (Bayer, Whippany, NJ) using 5 μL of whole blood collected at the time of cardiac puncture.
Histological Analysis
Following resection, lungs, hearts, livers, and kidneys were fixed in 10% neutral buffered formalin (Sigma Aldrich). Lungs were inflated with formalin to 5 cm of pressure prior to immersion. After 48 hours, samples were transferred to 70% ethanol, routinely processed and paraffin embedded, sectioned at 5 μm, and stained with hematoxylin and eosin. Multiple tissue sections of each organ were scored by a blinded veterinary pathologist for severity of injury ( Table 2) .
Gene Expression Analysis
Total RNA was purified from blood and tissue samples (RNeasy Plus Mini Kit for blood and RNeasy Plus Fibrous tissue kit for heart; Qiagen). Complimentary DNA (cDNA) was created using a high-capacity cDNA reverse-transcription kit (Life Technologies, Carlsbad, CA). Gene expression analysis was performed via quantitative real-time (qRT)-PCR using a Sensimix II kit (Bioline, Taunton, MA) with primer/probe sets for Ppara, Ppard, Pparg, medium-chain acyl-CoA dehydrogenase (Acadm), very long-chain acyl-CoA dehydrogenase (Acadvl), carnitine palmitoyltransferase 2 (Cpt2), and PPARγ coactivator 1 α (Pgc1a) (Life Technologies). Hypoxanthine guanine phosphoribosyl transferase 1 was used as the endogenous control gene. qRT-PCR was performed on an ABI 7900HT instrument (Life Technologies).
Protein Immunoblotting
Total protein was extracted from cardiac tissue by homogenization in radioimmunoprecipitation assay buffer and then quantified using the bicinchoninic acid assay (Thermo Fisher Scientific, Waltham, MA). Proteins (20 µg of protein per well) were resolved by gel electrophoresis on 4-12% Bis-Tris Plus Gels using the Bolt System (Life Technologies) and transferred to polyvinylidene difluoride membranes. Membranes were blocked with 5% bovine serum albumin in 0.1% Tris-Buffered Saline and Tween and then incubated in primary antibody solution overnight at 4°C. Rabbit anti-ACADM and anti-Vinculin antibodies were obtained from Abcam (ab92461 and ab129002, respectively, Cambridge, MA). Rabbit anti-ACADVL was obtained from Santa Cruz Biotechnology (sc-98338, Dallas, TX). Membranes were subsequently incubated with horse radish peroxidase-conjugated goat antirabbit antibody (Abcam, ab6721), developed using SuperSignal West Pico Chemiluminescent Substrate (Life Technologies), and imaged on a Bio-Rad Chemidoc imager (Bio-Rad, Hercules, CA).
Statistical Analysis
All statistics were computed using STATA 12/IC (Stata Corp LP, College Station, TX). Normally distributed data were compared with the two-group mean comparison test (t test) and one-way analyses of variance (ANOVAs). For gene expression analysis between two genotypes over multiple time points, the two-way ANOVA was used to detect interaction effects. Data not normally distributed were compared using nonparametric analyses, the two-sample Wilcoxon rank-sum (Mann-Whitney) and Kruskal-Wallis tests. Survival differences were calculated using the log-rank test of equality. For all statistical analyses, a p value of 0.05 was considered significant. The Bonferroni correction was used for multiple comparisons.
RESULTS
Leukocyte PPARα Expression in Experimental Polymicrobial Sepsis
In children with sepsis, PPARα expression is reduced in leukocytes (8) . Therefore, to determine whether PPARα expression responses in septic mice recapitulated human disease, messenger RNA (mRNA) expression of PPARα in peripheral blood leukocytes from WT mice was evaluated by qRT-PCR. Similar to humans, PPARα was profoundly down-regulated, with decreased expression maintained 72 hours after CLP ( Fig. 1) .
PPARα Expression in Nonhematopoietic Tissues Is Critical for Survival in Mice During Experimental Polymicrobial Sepsis
Consistent with prior observations (8), sepsis-induced mortality was markedly greater in Ppara -/mice compared with WT mice. Most Ppara -/mice succumbed to sepsis within 24 to 48 hours of CLP. Thereafter, the slopes of the survival curves were similar, indicating that PPARα-dependent effects occurred early in sepsis ( Fig. 2A) . PPARα is expressed broadly in both hematopoietic and nonhematopoietic tissues (10, 11) . Therefore, bone marrow chimeras of WT and Ppara -/mice were used to evaluate whether PPARα expression in leukocytes or in nonhematopoietic tissues was critical for survival. Marrow from either genotype did not affect survival of the recipient mice ( Fig. 2B) . For example, the survival curve of the Ppara -/mice transplanted with WT marrow paralleled that of the Ppara -/mice transplanted with Ppara -/bone marrow. Similarly, the WT chimera's survival curve mirrored that of the WT control. Therefore, even though previous data suggested that PPARα influences the immune response in sepsis (7, 8) , these results demonstrate that PPARα expression in nonhematopoietic tissues is more critical in determining survival outcomes than in hematopoietic cells.
PPARα Expression Protects Against Organ Injury in Experimental Polymicrobial Sepsis
PPARα is highly expressed in solid organs, and organ system failure is a common feature of sepsis (1, 5, 6) . Therefore, plasma biomarkers of heart, kidney, and liver injury were evaluated to assess whether differences in organ injury existed between WT and Ppara -/mice. Cardiac troponin-I, BUN, creatinine, and ALT activity were measured at baseline and 24 hours after sepsis initiation with CLP, when the steep decline in survival was observed in the Ppara -/mice (Fig. 2) . Plasma levels of cardiac troponin-I, BUN, and creatinine were all significantly higher in Ppara -/mice compared with WT mice. In contrast, plasma ALT activity was elevated to the same degree in both WT and Ppara -/mice ( Fig. 3) .
As assessed by tissue histology at 24 hours after CLP, neither lung nor liver showed signs of significant tissue injury in either genotype (data not shown). However, Ppara -/mice had higher severity scores in heart and kidney ( Fig. 4) . Although Ppara -/kidneys had zones of tubular degeneration and necrosis not seen in WT kidneys (Fig. 4B) , pathologic changes in Ppara -/cardiac muscle were most striking. We observed discrete areas of myocardial vacuolization (degeneration), hyalinization, and muscle fiber loss (necrosis) in the great majority of Ppara -/hearts that were not evident in WT tissue. In Ppara -/mice, this myocardial degeneration and necrosis were consistently more severe within the left ventricular free wall and to a lesser extent the interventricular septum, resulting in a "moth-eaten" appearance ( Fig. 4A) . Most of the mortality difference occurs between the 24-and 48-hr time points. B, Sepsis survival is not affected by reconstitution with opposite genotype bone marrow (BM) in chimeric mice. Irrespective of the type of bone marrow received, Ppara -/recipients had lower survival than WT recipients (p < 0.0001). Ppara -/mice with WT marrow had 5% survival and Ppara -/mice with Ppara -/marrow had 0% survival (p = 0.27). WT mice with WT marrow enjoyed 65% survival, whereas WT mice with Ppara -/marrow had 60% survival (p = 0.90). Figure 4 . Histologic severity scoring of heart and kidney tissue 24 hr after cecal ligation and puncture. A, Severity scores of heart tissue sections were consistently higher in Ppara -/mice (rank-sum 120.5 vs 15.5; p = 0.0013). Wild-type (WT) cardiomyocytes have normal appearance with cross-striations and viable nuclei. Ppara -/tissue has multifocal areas where cardiomyocytes are markedly swollen with fragmentation and loss of sarcoplasmic cross-striations and karyolytic or absent nuclei, indicative of degeneration and necrosis (arrowheads). Images taken from the left ventricle at ×20, scale = 100 μm. B, Similarly, Ppara -/mice have higher kidney injury scores (rank sum 88.5 vs 31.5; p = 0.0365). WT renal tubules and glomeruli are within normal limits. Ppara -/mice demonstrate multifocal to regional areas of injury in which renal tubules have swollen, pale epithelial cells, some with pyknotic or karyorrhectic nuclei (degeneration and necrosis). Few tubules also have loss of epithelium and contain luminal sloughed cells and debris (arrows). Adjacent renal tubules appeared normal (asterisk). Images taken from the renal cortex at ×20, scale = 100 μm (*p < 0.05, n = 5-11/group). WT Ppara −/− WT Ppara −/− * Figure 3 . Plasma biomarkers of organ injury. Twenty-four hours after cecal ligation and puncture (CLP), median cardiac troponin-I levels were significantly higher in Ppara -/mice compared with wild-type (WT) mice (0.95 vs 0.39 ng/mL, respectively; p = 0.0004). Blood urea nitrogen (BUN) was similarly elevated (103 mg/dL in Ppara -/mice vs 66 mg/dL in WT mice; p = 0.023) and creatinine levels (16.6 mg/dL elevation in Ppara -/mice vs 7.3 mg/dL in WT mice; p = 0.012). Plasma alanine aminotransferase (ALT) activity, though elevated in both WT and Ppara -/mice (1.9 and 2.2 mU/mL, respectively; p = 0.17), did not differ (*p < 0.05, n = 5-10 per group).
Ppara -/-Mice Have Profound Down-Regulation of Enzymes Related to Lipid Metabolism in the Heart in Experimental Polymicrobial Sepsis
The heart depends on FAO to provide a significant portion of its energy. Because many enzymes involved with fatty acid metabolism are regulated by PPARα (12, 13) , expression of genes related to FAO was evaluated to assess whether differences in PPARα-dependent regulation of fatty acid metabolism contributed to the injury seen in Ppara -/heart tissues after CLP. PPARα expression decreased in all tissues except in lungs in response to sepsis (Fig. 5A) . Notably, expression of PPARα in lung was low at baseline (average lung qRT-PCR cycle threshold was 30.1 compared with 24.9 in heart, 26.4 in kidney, and 24.8 in liver). Kidney and liver PPARα expression increased above the 24-hour time point expression nadir at 48 and 72 hours, but cardiac PPARα expression remained low. Because of the significant troponin elevations in Ppara -/mice coupled with the dramatic histologic findings in the heart and the profound and persistent down-regulation of PPARα in the heart, the relative expression of six genes related to PPARα function was evaluated in the heart. Medium-chain acyl-CoA dehydrogenase (Acadm), very long-chain acyl-CoA dehydrogenase (Acadvl), and carnitine palmitoyltransferase 2 (Cpt2) are downstream transcriptional targets regulated by PPARα, and their mRNA levels indicate the degree of PPARα activation (14) . These genes encode enzymes involved in FAO and lipid transport, respectively, and thus they function to provide energy to the cell. PPARγ coactivator 1-α (Pgc1a) is a protein that interacts with transcription factors, including PPARα, to positively regulate mitochondrial energy production and other intracellular metabolic processes (15) . PPARβ/δ (Ppard) and PPARγ (Pparg) are members of the same receptor family as PPARα (Ppara). Their expression was measured to assess both how their levels were changed in sepsis and whether absence of PPARα affected their expression.
In both WT and Ppara -/mice, cardiac mRNA expression of Acadm and Acadvl was decreased in response to sepsis. Expression of Cpt2 did not significantly change from genotype-specific basal levels (Fig. 5B) . WT expression of all three genes was greater than that seen in Ppara -/mice at the crucial 24-and 48-hour time points after CLP. Cardiac protein expression of ACADM and ACADVL appeared to increase in sepsis, but consistent with mRNA differences between genotypes, protein levels were lower in heart tissue of Ppara -/mice than in WT mice at every time point evaluated (Fig. 6) .
In WT hearts, Pgc1a expression was unchanged from baseline over the first 72 hours of sepsis. In the Ppara -/mice, B A Figure 5 . Cardiac gene expression in sepsis. A, Relative peroxisome proliferator-activated receptor (PPAR)-α expression levels in wild-type (WT) tissues. PPARα expression decreases at 24 hr in all organs but the lungs (on one-way analysis of variance [ANOVA] heart: p < 0.0001, lung: p = 0.448, liver: p = 0.018, and kidney: p = 0.004; #p < 0.05 for pairwise comparisons with PPARα expression at time 0). PPARα expression is persistently suppressed only in the heart. B, Expression of genes involved in lipid metabolism and transport decrease during sepsis. Expression of these genes is generally much lower in Ppara -/mice than in WT mice. Acadm, Acadvl, and Cpt2 all demonstrated significant (p < 0.05) interaction effects between genotype and time point on analysis by two-way ANOVA. Expression levels of Ppard and Pparg do not change dramatically in sepsis and do not differ significantly between genotypes in most instances (#p < 0.05 for pairwise comparison with same genotype control at time 0, *p < 0.05 for pairwise comparison with WT at the same time point, n = 5-10/group, error bars indicate sd). CLP = cecal ligation and puncture.
Critical Care Medicine www.ccmjournal.org e601 however, cardiac Pgc1a expression was significantly higher at 72 hours after CLP. At 24 and 48 hours after CLP, WT Pgc1a expression was greater than Ppara -/mouse expression. In both WT and Ppara -/mice, there was a slight increase in Ppard and Pparg expression after CLP. We did not observe any differences between the genotypes at any time tested for Ppard. The Ppara -/mice, however, had increased expression of Pparg at 24 hours after sepsis when compared with WT mice (Fig. 5B ).
Blood Glucose Levels Are Lower in Ppara -/-Mice in Experimental Polymicrobial Sepsis
Baseline blood glucose levels were similar in WT and Ppara -/mice. At 24 hours after CLP, both WT and Ppara -/mice became hypoglycemic, but the Ppara -/mice had significantly lower blood glucose levels (Fig. 7) .
DISCUSSION
Previously, we reported that reduced gene expression of PPARα in whole blood leukocytes in children with severe sepsis is associated with decreased survival and that Ppara -/mice showed increased mortality in CLP-induced polymicrobial sepsis (8) . However, despite our observations of a similar reduction in leukocyte PPARα expression in septic mice, the data presented in this article demonstrate that PPARα expression in nonhematopoietic tissues is most important to survival. PPARα may modulate leukocyte function, but survival in sepsis is more dependent on the role it plays in maintaining organ function.
Plasma biomarkers of heart and kidney injury were significantly elevated in Ppara -/mice compared with WT mice at early time points after CLP, and tissue histology revealed worse kidney injury and dramatically more cardiac damage in the Ppara -/mice. Interestingly, both of these organs have high energetic demands that rely primarily on FAO for adenosine triphosphate (ATP) production (12, 16) . Neither the lung nor the liver, which are much more versatile in their utilization of metabolic substrate, showed significant injury. These findings agree with recent reports that lung and liver injury are not early features of this sepsis model (17, 18) . Those investigations did not, however, specifically evaluate cardiac injury.
Cardiac dysfunction is commonly observed in patients with severe sepsis (19) (20) (21) (22) (23) (24) (25) , which may be explained by inflammation-induced changes to intracellular metabolism and ATP production. Reduced contribution of fatty acid substrates to cardiac metabolism has been reported in human subjects with septic shock (26) , and many nuclear hormone receptors and their cofactors are down-regulated in the heart in mice after lipopolysaccharide administration (27) . Lipopolysaccharide signaling through Toll-like receptor 4, c-Jun N-terminal kinase, and nuclear factor-κB triggers a myocardial fuel switch by suppressing FAO (28, 29) . Thus, it is evident that in sepsis, the heart shifts away from using fatty acid substrates for oxidative phosphorylation toward other energy sources. In humans with heart failure and in animal heart failure models, this shift in myocardial substrate utilization has been well documented-PPARα expression is reduced, the rate of FAO decreases, and aerobic glycolysis increases to maintain adequate ATP levels (12, 30, 31) . It is unknown if this substrate shift is adaptive or maladaptive.
Whether alteration of PPARα function contributes to cardiac dysfunction and altered energy utilization in human sepsis is unknown. However, studies in mice demonstrate the importance of PPARα in cardiac metabolism. Ppara -/mice have significantly lower constitutive expression of genes related to FAO in the heart (32, 33) . Gene expression changes correlated with decreased cardiac uptake of radiolabeled fatty acids and reduced fatty acid metabolism (33) .
In our study, PPARα mRNA expression in WT mice was significantly reduced in heart, kidney, and liver tissues during sepsis. Reduction of PPARα expression was greatest and most prolonged in the heart where decreased PPARα activity was also noted by concomitant down-regulation of genes encoding enzymes involved in FAO. Similar findings have been reported previously in the endotoxemia models of sepsis (27, 29) , supporting a conclusion that this observation is not a feature Figure 6 . Protein levels of fatty acid oxidation enzymes. Protein expression of both ACADM and ACADVL is lower in Ppara -/mice than in wild-type (WT) mice at every time point. On the ACADVL immunoblot, a nonspecific band (asterisk) appeared at a higher molecular weight than at the ACADVL band of interest. Vinculin is displayed as a protein loading control. This is a representative blot of five separate experiments (total n = 5-10/group). CLP = cecal ligation and puncture. Glucose levels are similar between genotypes at baseline (208 vs 204 mg/dL; p = 0.7084). After CLP-induced sepsis, levels drop in both wild-type (WT) and in Ppara -/mice but are lower in Ppara -/mice (78 vs 53 mg/dL, respectively; p = 0.0018) (*p < 0.05, n = 9-14/group, error bars indicate sd).
unique to the CLP model. Importantly, mRNA expression levels of FAO enzymes were significantly lower in Ppara -/mice than in WT mice.
It is interesting that protein levels of ACADM and ACADVL appear to have a discordant increase at the 24-and 48-hour time points while their mRNA levels decrease. This phenomenon is more dramatic in the WT mice than in the Ppara -/mice. Elevated enzyme levels may be due to increased translation of mRNA already present in the cell, decreased protein degradation, or by increased transcriptional activation mediated by other transcriptional activators (34) (35) (36) . The absolute quantity of FAO enzymes, however, does not determine rate of FAO, which is governed primarily by substrate availability and allosteric regulation (12, 37, 38) . Myocardial substrate utilization in sepsis is an area of active, ongoing research in our laboratory.
Both mRNA and protein expression of enzymes involved with FAO pathways are lower in the Ppara -/mice. This likely resulted in a critical decrement of energy provision from fatty acid substrates. Using a model of heart failure, Luptak et al demonstrated that cardiac dysfunction in Ppara -/mice is likely due to energy insufficiency and can be ameliorated by increasing expression of an insulin-independent glucose transporter in the heart (39) . In light of these findings, we propose that the increased sepsis mortality observed in Ppara -/mice is due to cardiovascular failure caused by insufficient energy production from fatty acid substrates. We observed more severe hypoglycemia in the Ppara -/mice compared with WT mice, but whether this contributed to impaired ability of Ppara -/myocardium to use glucose as an alternative to FAO cannot be determined based on our current data. Evaluating this possibility is a focus of ongoing work in our laboratory.
Additionally, we evaluated cardiac expression of PPARγ and PPARδ to assess whether these PPAR isoforms compensated for the absence of PPARα signaling in Ppara -/mice. No consistent patterns of up-regulation were observed indicating that compensatory increases in expression of these genes did not occur.
PGC-1α is a transcription factor coactivator, which interacts with a host of nuclear receptors, including the PPARs, to up-regulate genes involved in FAO and mitochondrial biogenesis (15) . We noted that although PGC-1α is not a transcriptional target of PPARα, the expression of PGC-1α is lower in the Ppara -/mice at 24 and 48 hours after CLP. This finding indicates that other systems of metabolic regulation are likely involved in the suppression of FAO in sepsis beyond PPARα signaling. Additionally, lower expression levels of PGC-1α may portend impaired mitochondrial function and altered mitochondrial numbers. Mitochondrial dysfunction has recently been discussed as a plausible, and possibly very important, mechanism of organ failure in sepsis (40, 41) . The results of the current study support further investigation of the role of mitochondrial dysfunction in sepsis-related organ dysfunction, especially in the heart.
CONCLUSIONS
In summary, we have confirmed our prior observations that mortality was increased in Ppara -/mice in sepsis. Furthermore, that increased mortality is not dependent on PPARα expression in hematopoietic cells, including immune cells, but rather on PPARα expression in nonhematopoietic tissues. Of the organs examined in our model, heart injury appears to be most prominent in the Ppara -/mice with sepsis. Cardiac mRNA expression of genes related to FAO is down-regulated in sepsis in both WT and Ppara -/mice, but levels are significantly lower in Ppara -/mice. Protein levels of FAO enzymes are also lower in Ppara -/mice. We conclude that increased mortality in Ppara -/mice is likely due to cardiac failure resulting from inadequate energy production due to insufficient FAO. Because similar metabolic changes have been noted in both mouse models of heart failure and human heart failure, we propose that these findings could have important implications for cardiovascular function in human sepsis. Returning to our initial observation that children with severe septic shock and multisystem organ failure have decreased expression of PPARα, we feel that a similar metabolic mechanism may contribute to their increased morbidity and mortality (6, 8) . Future work will be directed at linking our observations of decreased FAO enzyme expression with impaired heart function and assessing strategies to improve cardiac performance by enhancing substrate utilization for energy production.
